Waldencast plc [WALD] vs Procter & Gamble [PG] Detailed Stock Comparison
Waldencast plc
NASDAQ
Loading...
Procter & Gamble
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Waldencast plc wins in 6 metrics, Procter & Gamble wins in 10 metrics, with 0 ties. Procter & Gamble appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Waldencast plc | Procter & Gamble | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 24.09 | N/A |
| Price-to-Book Ratio | 0.26 | 7.18 | Waldencast plc |
| Debt-to-Equity Ratio | 24.95 | 69.86 | Waldencast plc |
| PEG Ratio | -15.60 | 21.16 | Waldencast plc |
| EV/EBITDA | 676.12 | 16.19 | Procter & Gamble |
| Profit Margin (TTM) | -15.50% | 18.95% | Procter & Gamble |
| Operating Margin (TTM) | -18.31% | 25.15% | Procter & Gamble |
| EBITDA Margin (TTM) | N/A | 25.15% | N/A |
| Return on Equity | -6.49% | 31.24% | Procter & Gamble |
| Return on Assets (TTM) | -3.32% | 10.91% | Procter & Gamble |
| Free Cash Flow (TTM) | $-11.83M | $14.04B | Procter & Gamble |
| Dividend Yield | N/A | 1.92% | N/A |
| 1-Year Return | -57.67% | -9.92% | Procter & Gamble |
| Price-to-Sales Ratio (TTM) | 0.70 | 4.36 | Waldencast plc |
| Enterprise Value | $409.73M | $395.87B | Procter & Gamble |
| EV/Revenue Ratio | 1.50 | 4.70 | Waldencast plc |
| Gross Profit Margin (TTM) | N/A | 49.11% | N/A |
| Revenue per Share (TTM) | $2 | $36 | Procter & Gamble |
| Earnings per Share (Diluted) | $-0.39 | $6.52 | Procter & Gamble |
| Beta (Stock Volatility) | -0.53 | 0.37 | Waldencast plc |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Waldencast plc vs Procter & Gamble Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Waldencast plc | 6.71% | -8.02% | -18.13% | -37.92% | -53.00% | -60.16% |
| Procter & Gamble | 0.66% | 0.77% | 4.92% | -5.20% | -9.92% | -4.71% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Waldencast plc | -57.67% | -82.87% | -84.87% | -84.87% | -84.87% | -84.87% |
| Procter & Gamble | -9.92% | 13.01% | 14.50% | 131.18% | 161.87% | 177.98% |
Performance & Financial Health Analysis: Waldencast plc vs Procter & Gamble
| Metric | WALD | PG |
|---|---|---|
| Market Information | ||
| Market Cap | $32.08M | $411.73B |
| Market Cap Category | Micro cap | Mega cap |
| 10 Day Avg. Volume | 870,850 | 6,295,460 |
| 90 Day Avg. Volume | 385,483 | 7,028,630 |
| Last Close | $1.59 | $159.21 |
| 52 Week Range | $1.48 - $4.39 | $149.91 - $180.43 |
| % from 52W High | -63.82% | -11.76% |
| All-Time High | $12.10 (Oct 03, 2022) | $180.43 (Nov 25, 2024) |
| % from All-Time High | -86.86% | -11.76% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | 0.02% |
| Quarterly Earnings Growth | N/A | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.16% | 0.19% |
| Operating Margin (TTM) | -0.18% | 0.25% |
| Return on Equity (TTM) | -0.06% | 0.31% |
| Debt to Equity (MRQ) | 24.95 | 69.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.91 | $21.88 |
| Cash per Share (MRQ) | $0.13 | $4.08 |
| Operating Cash Flow (TTM) | $-8,820,000 | $17.82B |
| Levered Free Cash Flow (TTM) | $8.34M | $11.38B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.92% |
| Last 12-Month Dividend | N/A | $3.03 |
Valuation & Enterprise Metrics Analysis: Waldencast plc vs Procter & Gamble
| Metric | WALD | PG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 24.09 |
| Forward P/E | -15.60 | 21.16 |
| PEG Ratio | -15.60 | 21.16 |
| Price to Sales (TTM) | 0.70 | 4.36 |
| Price to Book (MRQ) | 0.26 | 7.18 |
| Market Capitalization | ||
| Market Capitalization | $32.08M | $411.73B |
| Enterprise Value | $409.73M | $395.87B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.50 | 4.70 |
| Enterprise to EBITDA | 676.12 | 16.19 |
| Risk & Other Metrics | ||
| Beta | -0.53 | 0.37 |
| Book Value per Share (MRQ) | $5.91 | $21.88 |
Financial Statements Comparison: Waldencast plc vs Procter & Gamble
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | WALD | PG |
|---|---|---|
| Revenue/Sales | $0 | $20.89B |
| Cost of Goods Sold | N/A | $10.63B |
| Gross Profit | N/A | $10.26B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-4.40M | $4.35B |
| EBITDA | $-11.30M | $5.46B |
| Pre-Tax Income | $2.77M | $4.52B |
| Income Tax | N/A | $895.00M |
| Net Income (Profit) | $2.77M | $3.63B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | WALD | PG |
|---|---|---|
| Cash & Equivalents | $14.80M | $9.56B |
| Total Current Assets | $103.62M | $25.39B |
| Total Current Liabilities | $76.89M | $36.06B |
| Long-Term Debt | $149.86M | $25.70B |
| Total Shareholders Equity | $729.94M | $52.28B |
| Retained Earnings | $-289.20M | $129.97B |
| Property, Plant & Equipment | $0 | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | WALD | PG |
|---|---|---|
| Operating Cash Flow | $5.41M | $3.71B |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-1.59M | $2.85B |
| Debt Repayment | N/A | $-1.05B |
| Common Stock Repurchase | N/A | $-1.35B |
Short Interest & Institutional Ownership Analysis
| Metric | WALD | PG |
|---|---|---|
| Shares Short | 585,305 | 16.72M |
| Short Ratio | 4.43 | 2.21 |
| Short % of Float | 0.01% | 0.01% |
| Average Daily Volume (10 Day) | 870,850 | 6,295,460 |
| Average Daily Volume (90 Day) | 385,483 | 7,028,630 |
| Shares Outstanding | 122.50M | 2.34B |
| Float Shares | 32.85M | 2.34B |
| % Held by Insiders | 0.57% | 0.00% |
| % Held by Institutions | 0.30% | 0.70% |
Dividend Analysis & Yield Comparison: Waldencast plc vs Procter & Gamble
| Metric | WALD | PG |
|---|---|---|
| Last 12-Month Dividend | N/A | $3.03 |
| Last 12-Month Dividend Yield | N/A | 1.92% |
| 3-Year Avg Annual Dividend | N/A | $3.51 |
| 3-Year Avg Dividend Yield | N/A | 0.63% |
| 3-Year Total Dividends | N/A | $10.53 |
| Ex-Dividend Date | N/A | Jan 24, 2025 |